Your browser doesn't support javascript.
[Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience]. / Tocilizumab más glucocorticoides para tratar pacientes graves y en situación crítica infectados por COVID-19. Experiencia de un centro.
Jiménez-Brítez, Gustavo; Ruiz, Pablo; Soler, Xavier.
  • Jiménez-Brítez G; Intensive Care Unit, Centro Médico Teknon, Quironsalud, Barcelona, Spain; Facultad de Ciencias de la Salud, Universidad Nacional del Este (FACISA-UNE), Paraguay. Electronic address: gustavo.jimenezb@quironsalud.es.
  • Ruiz P; Intensive Care Unit, Centro Médico Teknon, Quironsalud, Barcelona, Spain.
  • Soler X; Intensive Care Unit, Centro Médico Teknon, Quironsalud, Barcelona, Spain.
Med Clin (Barc) ; 155(9): 410-411, 2020 11 13.
Article in English, Spanish | MEDLINE | ID: covidwho-644308
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Methylprednisolone / Critical Illness / Coronavirus Infections / Antibodies, Monoclonal, Humanized / Betacoronavirus / Cytokine Release Syndrome Type of study: Case report / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English / Spanish Journal: Med Clin (Barc) Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Methylprednisolone / Critical Illness / Coronavirus Infections / Antibodies, Monoclonal, Humanized / Betacoronavirus / Cytokine Release Syndrome Type of study: Case report / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English / Spanish Journal: Med Clin (Barc) Year: 2020 Document Type: Article